JME-001 phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma.
Yosuke MiyamotoToshiyuki KozukiKeisuke AoeSae WadaDaijiro HaradaMichihiro YoshidaJun SakuraiKatsuyuki HottaNobukazu FujimotoPublished in: Journal for immunotherapy of cancer (2022)
UMIN000030892.